Insiders / David D. Chang, M.D., Ph.D.
David D. Chang, M.D., Ph.D.
CIK 1611024personinsiderbeneficial owner
Companies
1
First seen
Feb 4, 2026
Last activity
Mar 18, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Allogene Therapeutics, Inc. · ALLO | 5,150,599 | — |
All securities held
3 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Allogene Therapeutics, Inc. | Common Stock | 5,150,599 |
| Allogene Therapeutics, Inc. | Stock Option (Right to buy)Derivative | 1,387,931 |
| Allogene Therapeutics, Inc. | Restricted Stock UnitDerivative | 392,586 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Sell | ALLO Allogene Therapeutics, Inc. Common Stock | $171.5K | -95K -1.80% | 5,185,862 1.50% of shares | medium |
| Mar 16, 2026 | Sell | ALLO Allogene Therapeutics, Inc. Common Stock | $118.0K | -48K -0.92% | 5,150,599 1.49% of shares | medium |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Restricted Stock Unit | — | +393K | 392,586 0.11% of shares | low |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Stock Option (Right to buy) | — | +1.4M | 1,387,931 0.40% of shares | low |